D. E. Shaw & Co., Inc. Spectrum Pharmaceuticals Inc Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.32 - $0.52 $886,879 - $1.44 Million	-2,771,497 Reduced 72.08%	1,073,491 $397,000
Q3 2022 Nov 14, 2022	SELL	$0.43 - $1.56 $1.81 Million - $6.56 Million	-4,206,870 Reduced 52.25%	3,844,988 $1.65 Million
Q2 2022 Aug 15, 2022	BUY	$0.7 - $1.4 $144,292 - $288,584	206,132 Added 2.63%	8,051,858 $6.28 Million
Q1 2022 May 16, 2022	BUY	$0.63 - $1.59 $4.4 Million - $11.1 Million	6,983,089 Added 809.5%	7,845,726 $10.1 Million
Q4 2021 Feb 14, 2022	BUY	$1.27 - $2.42 $774,715 - $1.48 Million	610,012 Added 241.47%	862,637 $1.1 Million
Q3 2021 Nov 15, 2021	SELL	$2.15 - $3.82 $689,661 - $1.23 Million	-320,773 Reduced 55.94%	252,625 $550,000
Q2 2021 Aug 16, 2021	BUY	$2.89 - $4.45 $143,225 - $220,537	49,559 Added 9.46%	573,398 $2.15 Million
Q1 2021 May 17, 2021	SELL	$2.9 - $4.09 $1.76 Million - $2.49 Million	-608,001 Reduced 53.72%	523,839 $1.71 Million
Q4 2020 Feb 16, 2021	BUY	$3.38 - $5.14 $645,769 - $982,027	191,056 Added 20.31%	1,131,840 $3.86 Million
Q3 2020 Nov 16, 2020	SELL	$2.99 - $4.9 $1.85 Million - $3.02 Million	-617,291 Reduced 39.62%	940,784 $3.84 Million
Q2 2020 Aug 14, 2020	BUY	$2.11 - $3.38 $1.87 Million - $3 Million	887,469 Added 132.34%	1,558,075 $5.27 Million
Q1 2020 May 15, 2020	BUY	$1.83 - $3.45 $811,235 - $1.53 Million	443,298 Added 195.02%	670,606 $1.56 Million
Q4 2019 Feb 14, 2020	BUY	$3.5 - $10.35 $795,578 - $2.35 Million	227,308 New	227,308 $827,000
Q4 2018 Feb 14, 2019	SELL	$6.39 - $16.99 $258,322 - $686,837	-40,426 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$16.52 - $24.82 $6.4 Million - $9.62 Million	-387,421 Reduced 90.55%	40,426 $679,000
Q2 2018 Aug 14, 2018	SELL	$14.31 - $21.75 $13.5 Million - $20.5 Million	-942,770 Reduced 68.78%	427,847 $8.97 Million
Q1 2018 May 15, 2018	SELL	$16.09 - $23.07 $9.94 Million - $14.3 Million	-617,860 Reduced 31.07%	1,370,617 $22.1 Million
Q4 2017 Feb 14, 2018	SELL	$13.36 - $20.73 $11.5 Million - $17.8 Million	-860,691 Reduced 30.21%	1,988,477 $37.7 Million
Q3 2017 Nov 14, 2017	BUY	$8.75 - $14.07 $24.9 Million - $40.1 Million	2,849,168	2,849,168 $40.1 Million

Others Institutions Holding SPPI

# of Institutions

Shares Held

115K

Call Options Held

Put Options Held

Tekla Capital Management LLC

115K
Shares

$0
0.0% of portfolio

View Full List

About SPECTRUM PHARMACEUTICALS INC

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

More about SPPI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account